Targeted Endoscopic Imaging

Gastrointestinal Endoscopy Clinics of North America

Volumn 19, Issue 2, 2009, Pages 283-298

  Li, Meng ^a   Wang, Thomas D ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Early detection; Endoscopy; Molecular imaging; Targets

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORESCENT DYE; MONOCLONAL ANTIBODY; PROTEINASE;

ATROPHIC GASTRITIS; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CELL SURFACE; CHEMOPROPHYLAXIS; COLON CANCER; CONFOCAL MICROSCOPY; DIGESTIVE SYSTEM CANCER; DIGESTIVE TRACT ENDOSCOPY; HUMAN; IN VIVO STUDY; INTESTINE MUCOSA; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; ULCERATIVE COLITIS; WHITE LIGHT ENDOSCOPY;

CELL TRANSFORMATION, NEOPLASTIC; ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; MOLECULAR DIAGNOSTIC TECHNIQUES; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY;

EID: 65449134283     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.giec.2009.02.001     Document Type: Review

References (50)

1. Sivak M.V. Gastrointestinal endoscopy: past and future. Gut 55 8 (2006) 1061-1064
2. Kumar V., Fausto N., and Abbas A. Robbins & Cotran pathologic basis of disease. 7th edition (2004), WB Saunders Company, Philadelphia
3. Levine D.S., Haggitt R.C., Blount P.L., et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 105 1 (1993) 40-50
4. Jess T., Loftus Jr. E.V., Velayos F.S., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology 130 4 (2006) 1039-1046
5. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat Med 10 8 (2004) 789-799
6. Serafini A.N., Klein J.L., Wolff B.G., et al. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies. J Clin Oncol 16 5 (1998) 1777-1787
7. Willkomm P., Bender H., Bangard M., et al. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. J Nucl Med 41 10 (2000) 1657-1663
8. Weissleder R., Tung C.H., Mahmood U., et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17 4 (1999) 375-378
9. Tung C.H., Mahmood U., Bredow S., et al. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 60 17 (2000) 4953-4958
10. Bremer C., Bredow S., Mahmood U., et al. Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Radiology 221 2 (2001) 523-529
11. Kang H.W., Torres D., Wald L., et al. Targeted imaging of human endothelial-specific marker in a model of adoptive cell transfer. Lab Invest 86 6 (2006) 599-609
12. Laxman B., Hall D.E., Bhojani M.S., et al. Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A 99 26 (2002) 16551-16555
13. Messerli S.M., Prabhakar S., Tang Y., et al. A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. Neoplasia 6 2 (2004) 95-105
14. Maley C.C., Galipeau P.C., Finley J.C., et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet 38 4 (2006) 468-473
15. Giacomini C.P., Leung S.Y., Chen X., et al. A gene expression signature of genetic instability in colon cancer. Cancer Res 65 20 (2005) 9200-9205
16. Fitzgerald R.C. Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut 55 12 (2006) 1810-1820
17. Syngal S., Clarke G., and Bandipalliam P. Potential roles of genetic biomarkers in colorectal cancer chemoprevention. J Cell Biochem Suppl 34 (2000) 28-34
18. Kruszewski W.J., Rzepko R., Wojtacki J., et al. Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma. Neoplasma 51 1 (2004) 38-43
19. McKerrow J.H., Bhargava V., Hansell E., et al. A functional proteomics screen of proteases in colorectal carcinoma. Mol Med 6 5 (2000) 450-460
20. Kioi M., Yamamoto K., Higashi S., et al. Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model. Oncogene 22 54 (2003) 8662-8670
21. Tanioka Y., Yoshida T., Yagawa T., et al. Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer 89 11 (2003) 2116-2121
22. Folli S., Wagnières G., Pèlegrin A., et al. Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen. Proc Natl Acad Sci U S A 89 17 (1992) 7973-7977
23. Ito S., Muguruma N., Kusaka Y., et al. Detection of human gastric cancer in resected specimens using a novel infrared fluorescent anti-human carcinoembryonic antigen antibody with an infrared fluorescence endoscope in vitro. Endoscopy 33 10 (2001) 849-853
24. Sagara M., Yonezawa S., Nagata K., et al. Expression of mucin 1 (MUC1) in esophageal squamous-cell carcinoma: its relationship with prognosis. Int J Cancer 84 3 (1999) 251-257
25. Utsunomiya T., Yonezawa S., Sakamoto H., et al. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res 4 11 (1998) 2605-2614
26. Schechter A.L., Hung M.C., Vaidyanathan L., et al. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229 4717 (1985) 976-978
27. Yu D., and Hung M.C. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 19 53 (2000) 6115-6121
28. Ortega P., Morán A., de Juan C., et al. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability. Clin Cancer Res 14 4 (2008) 995-1001
29. Marten K., Bremer C., Khazaie K., et al. Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. Gastroenterology 122 2 (2002) 406-414
30. Alencar H., Funovics M.A., Figueiredo J., et al. Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection-study in mice. Radiology 244 1 (2007) 232-238
31. Kuusela P., Jalanko H., Roberts P., et al. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer 49 2 (1984) 135-139
32. Reichelt U., Duesedau P., Tsourlakis M., et al. Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus. Mod Pathol 20 1 (2007) 120-129
33. Pegram M.D., and Reese D.M. Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular endothelial growth factor. Semin Oncol 29 3 Suppl 11 (2002) 29-37
34. Emlet D.R., Brown K.A., Kociban D.L., et al. Response to trastuzumab, erlotinib, and bevacizumab, alone and in combination, is correlated with the level of human epidermal growth factor receptor-2 expression in human breast cancer cell lines. Mol Cancer Ther 6 10 (2007) 2664-2674
35. Rauser S., Weis R., Braselmann H., et al. Significance of HER2 low-level copy gain in Barrett's cancer: implications for fluorescence in situ hybridization testing in tissues. Clin Cancer Res 13 17 (2007) 5115-5123
36. Arteaga C.L., O'Neill A., Moulder S.L., et al. A phase I-II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancer. Clin Cancer Res 14 19 (2008) 6277-6283
37. Medina P.J., and Goodin S. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases. Clin Ther 30 8 (2008) 1426-1447
38. Funovics M., Weissleder R., and Tung C.H. Protease sensors for bioimaging. Anal Bioanal Chem 377 6 (2003) 956-963
39. Available at:. http://www.visenmedical.com Accessed March 30, 2009
40. Keller R., Winde G., Terpe H.J., et al. Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen in patients with colorectal carcinoma and adenoma. Endoscopy 34 10 (2002) 801-807
41. Bando T., Muguruma N., Ito S., et al. Basic studies on a labeled anti-mucin antibody detectable by infrared-fluorescence endoscopy. J Gastroenterol 37 4 (2002) 260-269
42. Kelly K., Alencar H., Funovics M., et al. Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res 64 17 (2004) 6247-6251
43. Lu S., and Wang T.D. In vivo cancer biomarkers of esophageal neoplasia. Cancer Biomark 4 6 (2008) 341-350
44. Hsiung P.L., Hardy J., Friedland S., et al. Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat Med 14 4 (2008) 454-458
45. Ito S., Muguruma N., Kimura T., et al. Principle and clinical usefulness of the infrared fluorescence endoscopy. J Med Invest 53 1-2 (2006) 1-8
46. Uedo N., Higashino K., Ishihara R., et al. Diagnosis of colonic adenomas by new autofluorescence imaging system: a pilot study. Digestive Endoscopy 19 S1 (2007) S134-S138
47. In: Pawley J. (Ed). Handbook of biological confocal microscopy. 3rd edition (1996), Plenum, New York
48. Kiesslich R., Burg J., Vieth M., et al. Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology 127 3 (2004) 706-713
49. Wang T.D., Friedland S., Sahbaie P., et al. Functional imaging of colonic mucosa with a fibered confocal microscope for real-time in vivo pathology. Clin Gastroenterol Hepatol 5 11 (2007) 1300-1305
50. US Food and Drug Administration. Available at:. http://www.fda.gov/CDER Accessed March 30, 2009